Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This study is a multicenter trial of treatment for young ALL patients. All ALL patients will
receive the same steroid pre-phase in order to evaluate sensitivity or resistance. Then,
patients will be included into 3 specific trials according to biological features
(immunophenotype, cytogenetics, and molecular biology).
Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) 2005:
- T ALL or B ALL non Ph (N=810 patients planned).
- GRAALL 2005 R: B ALL non Ph CD20+ (N=220 patients planned).
- GRAAPH 2005: ALL Ph+ (N=270 patients planned)
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborator:
Group for Research in Adult Acute Lymphoblastic Leukemia